Infective endo. for 18th eschs marriot

1,296 views
1,175 views

Published on

ESCTS 2012

Published in: Health & Medicine
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
1,296
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Infective endo. for 18th eschs marriot

  1. 1. SURGICAL TREATMENT OFBACTERIAL ENDOCARDITIS Kasr Elaini ExperienceEl-Sayed AKL (MD) , Tarek Mohsen (MD), Ihab Abdelfattah (MD), Hosam Fathy and A. Badreldin Cairo University . March -2012
  2. 2. INFECTIVE ENDOCARDIRTIS INFECTIVE 1986
  3. 3. INFECTIVE ENDOCARDIRTIS 2003
  4. 4. INFECTIVE ENDOCARDITIS Still a challenge !! DIAGNOSTIC DILEMMA : *Vague general manifestations *Empirical antibiotics. *Diagnostic criteria . MANAGEMENT DILEMMA : *When to operate ? * What to do ? Repair or Replace ? *What valve substitute ?
  5. 5. INFECTIVE ENDOCARDITIS Problems at surgery: 1- Friable Tissues & distorted anatomy. 2- Bad general condition, progressive Hepatorenal and heart failure . 3- Extension of infection may lead to : *LEAFLET DESTUCTION . *ABSCESS FORMATION . *VEGETATION >>>> EMBOLISATION . *LOCAL EXTENSION >>>> FISTULATION
  6. 6. INFECTIVE ENDOCARDITISOLD STRATIGY:* 4-6 WEEKS OF ANTIBIOTICS .* LOCAL & SYSTEMIC STRELIZATIONWHY??* To reduce surgical risk.* To reduce recurrence rate.
  7. 7. Complicated infective endocarditis• Heart failure• No control of infection• Big vegetations and embolic risk• Perivalvular infection• Valvular obstruction• Unstable prosthesis• Prosthetic infective endocarditis• Fungal infective endocarditis• Difficult-to-treat microorganisms• Neurological complications
  8. 8. When to operate ?
  9. 9. When to operate ?Current best practices and guidelines Indications for surgical intervention in infective endocarditisLars Olaison, MD, PhD(a), Go¨ sta Pettersson, MD, PhD(b) a -Department of Infectious Diseases, Sahlgrenska University Hospital, S-416 85 Go¨ teborg, Sweden b- The Cleveland Clinic Foundation, Thoracic and Cardiovascular Surgery/F25,9500 Euclic Avenue, Cleveland, OH 44195, USA Infect Dis Clin N Am 16 (2002) 453–475
  10. 10. BACTERIAL ENDOCARDITIS Between Jan 2000 and Oct. 2010 148 patients Age 6 – 70 ( mean 34.4 y ) 39% Male Female 61%
  11. 11. Underlying Cardiac Disease Rheumatic H.D. = 65 Prosthetic V.E. = 32 Degenerative = 2 Infected PM = 2 Congenital = 11 Infected homograft = 1 Healthy Native Valve = 24 %
  12. 12. Blood Culure +ve in 60 % Causative organisms Staph. Aureus 4% Strep. Viridans 4% E. Coli 9% 24% 5% Aspergillus 7% Staph. Coagulase - ve Bartonella 9% 15% Microaerophilic strept 11% 12% Candida Brucella Others
  13. 13. Main indications of surgery Uncontrolled infection 11% 9% Large vegetation23% CHF 30% Aortic root abcess 27% Recc. Emboli
  14. 14. Main indications of surgery Congestive Heart failure = 74 Large Vegetations = 68 Uncontrolled Infection = 47 Recurrent Emboli = 18 aortic root Abscess = 17More than one indication in > 40%
  15. 15. Valve Affection Isolated Mitral Valve = 64 Isolated Aortic Valve = 40 Isolated Tricuspid Valve = 16 Mitral + Aortic = 20 Mitral + Aortic + Tricuspid= 6 Mitral + Tricuspid = 2
  16. 16. Types of Surgery for Mitral valve endocarditis 30 25 20 15 10 Mitral valve 5 endocarditis 0 M M M V V V R bi re op pa ro ir th es is
  17. 17. Mitral valve procedures ( 64 patients ) :.Prosthetic MVR 45.MV repair 17.MV bioprosthesis 2
  18. 18. Isolaed Mitral Valve Endocarditis
  19. 19. Fungal prosthetic endocarditis, 4th time redo – Omental flap
  20. 20. Mitral Repair
  21. 21. Aortic valve procedures (40 patients) : . Homograft 6 . AVR 28 .AVR+VSD 1 .AVR+subaortic membrane 2 . Bental 3
  22. 22. Extension to pericardium
  23. 23. Aortic root abscess
  24. 24. Huge Vegetation
  25. 25. At Operation
  26. 26. Abscess wall Huge veget.
  27. 27. Aortic root replacement With coronary reimplantation Right coronary Left coronary
  28. 28. Aortic Valve Replacement
  29. 29. Huge fungal pseudoaneurysm
  30. 30. Homograft Root Replacement
  31. 31. Tricuspid Valve Operations=16 Bioprosthesis TVR = 11 Tricuspid V Repair = 5
  32. 32. Types of surgery for Tricuspid valve endocarditis 4 3.5 3 2.5 2 1.5 1 TV 0.5 endocarditis 0 TV TV bi re op pa ir ro th es is
  33. 33. Tricuspid Endocarditis
  34. 34. Isolated Tricuspid Valve Endocarditis = 4
  35. 35. Isolated Tricuspid Valve Replacement
  36. 36. Surgical Outcome 28 Patients = 19 % Operative = 2 (1.5%) Postoperative = 26 (17.5%)
  37. 37. CONCLUSIONSDecision is based on :* Careful daily clinical evaluation.* Microbiological tests ( Follow up Bl. Cultyres). * Repeated Echocardiography
  38. 38. CONCLUSIONSWhen to operate ?* A team work decision .* Decision is dictated by clinical condition, Laboratory tests and echocardiography.* Reluctance leads to deterioration.* Few days of antibiotics are enough .* Risk should be explained .
  39. 39. CONCLUSIONSSURGICAL RULES :* Maximum debridement .* Local sterilization .* Consider changing operative strategy .* Biological valves are better than prosthetic .* Prosthetic valves are better than delay .
  40. 40. Thank you
  41. 41. When Exaclty To Operate ?Indication Evidence basedEmergency indication for cardiac surgery (same day)1. Acute AR with early closure of mitral valve A2. Rupture of a sinus Valsalva aneurysm into theright heart chamber A3. Rupture into the pericardium A
  42. 42. When Exactly To Operate ?Urgent indication for cardiac surgery (within 1–2 days)4. Valvular obstruction A5. Unstable prosthesisA6. Acute AR or MR with heart failure, NYHA III–IV A7. Septal perforationA8. Evidence of annular or aortic abscess, sinus or aortic trueor false aneurysm, fistula formation, or new onset conductiondisturbancesA9. Major embolism+mobile vegetation >10 mm+appropriateantibiotic therapy <7–10 d B10. Mobile vegetation >15 mm+appropriate antibiotic therapy<7–10 d C11. No effective antimicrobial therapy available A
  43. 43. When Exactly To Operate ?Elective indication for cardiac surgery (earlier is usuallybetter)12. Staphylococcal prosthetic valve endocarditis B13. Early prosthetic valve endocarditis (£2 mo after surgery) B14. Evidence of progressive paravalvular prosthetic leak A15. Evidence of valve dysfunction and persistent infection after7–10 d of appropriate antibiotic therapy, as indicated bypresence of fever or bacteremia, provided there are nononcardiac causes for infection A16. Fungal endocarditis caused by a moldA17. Fungal endocarditis caused by a yeast B18. Infection with difficult-to-treat organisms B19. Vegetation growing larger during antibiotic therapy >7 dC
  44. 44. Main indications of surgery Uncontrolled infection 11% 9% Large vegetation23% CHF 30% Aortic root abcess 27% Recc. Emboli
  45. 45. S.A.MAbscess wall
  46. 46. Outside Inside Aotric wall abscess
  47. 47. Surgery for Native I.E* If vegetations are larger than 10 mm onthe mitral valve or if they are increasing insize despite antibiotic therapy or if theyrepresent mitral kissing vegetations,early surgery should also be considered.* The prognosis of right-sided IE isfavourable. Surgery is necessary if tricuspidvegetations are larger than 20 mm afterrecurrent pulmonary emboli. esc Guidelines 2004
  48. 48. Surgery for Prosthetic I.EThe following indications are accepted:* Early PVE (less than 12 months after surgery) + * Late PVE complicated by prosthesisdysfunction including significant perivalvular leaksor obstruction, persistent positive blood cultures,abscess formation,conduction abnormalities, andlarge vegetations, particularly if staphylococci arethe infecting agents esc Guidelines 2004
  49. 49. Surgery for Native I.E* Heart failure due to acute aortic regurgitation;* Heart failure due to acute mitral regurgitation;* Persistent fever and demonstration of bacteremia formore than 8 days despite adequate antimicrobialtherapy;* Demonstration of abscesses, pseudoaneurysms, abnormalcommunications like fistulas or rupture of one ormore valves, conduction disturbances, myocarditisor other findings indicating local spread (locallyuncontrolled infection);* Involvement of microorganisms which are frequentlynot cured by antimicrobial therapy (e.g. fungi;Brucella and Coxiella) or microorganisms which havea high potential for rapid destruction of cardiacstructures (e.g. S. lugdunensis). esc Guidelines 2004
  50. 50. Pattern of Valve Affection Isolated Mitral Valve = 36 Isolated Aortic Valve = 28 Isolated Tricuspid Valve = 4 Double or Triple Valve = 30
  51. 51. Isolaed Mitral Valve Endocarditis = 36
  52. 52. Types of Surgery for Mitral valve endocarditis 30 25 20 15 10 Mitral valve 5 endocarditis 0 M M M V V V R bi re op pa ro ir th es is
  53. 53. Isolaed Aortic Valve Endocarditis = 28
  54. 54. Types of surgery for Aoric valve endocarditis 20 18 16 14 12 10 8 6 Ao. Valve 4 endocarditis 2 0 A B A A A en VR VR VR o Ho tal + + m VS p SA og ro D M c ra ed ft ur e
  55. 55. Aortic Valve Replacement
  56. 56. Types of surgery for Tricuspid valve endocarditis 4 3.5 3 2.5 2 1.5 1 TV 0.5 endocarditis 0 TV TV bi re op pa ir ro th es is
  57. 57. Surgical Outcome 12 Patients = 12 % Operative =4 Postoperative =8
  58. 58. CONCLUSIONSWhen to operate ?* A team work decision .* Decision is dictated by clinical condition.* Reluctance may allow deterioration.* Few days of antibiotics are enough .* Risk should be explained .

×